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Is Screening of the Candidate Gene Necessary in Unrelated
Partners of Members of Families with Herlitz Junctional
Epidermolysis Bullosa?
To the Editor:
Epidermolysis bullosa (EB) refers to a heterogeneous group of
mechanobullous disorders, in which minor trauma leads to blister
formation on skin and mucous membranes. Three major groups of
EB have been de®ned based on the level of tissue separation in the
skin: (a) intraepidermal cleavage in EB simplex, (b) cleavage within
the lamina lucida in junctional forms of EB, and (c) separation
below the lamina densa in dystrophic EB (for review see Fine et al,
1999). In a total of 10 different genes mutations have been found
(Pulkkinen and Uitto, 1999). In Herlitz junctional EB (H-JEB)
mutations in the genes LAMA3, LAMB3, and LAMC2 encoding
for laminin 5 subunit polypeptides have been identi®ed (Pulkkinen
& Uitto, 1999). This variant of EB has an incidence of 1:2,500,000
(Fine et al, 1999), suggesting that reoccurence of H-JEB in families
with partners originating from outside of the nuclear family is rare.
Therefore, scanning of the affected gene of the partner for the same
or other mutations is usually not performed in this setting.
We have recently observed a family with a child with H-JEB and
two unaffected siblings. The parents, who originated from the same
geographical area, were heterozygous carriers of the mutation
Q864X in the LAMC2 gene. The affected child was homozygous
for this nonsense mutation and died at the age of 6 mo (Fig 1).
When the sister of the mother became pregnant with a partner
being from a geographically completely different area we calculated
the risk of reoccurence of H-JEB to be 0.0016%, virtually
excluding another affected child. The ®rst newborn from this
union, however, also had junctional EB. Mutation analysis revealed
that the child was compound heterozygous for the maternal
Q864X mutation and a paternal 4 bp deletion at the intron/exon
border of exon 3 (termed 521 + 3del4) in the LAMC2 gene (Fig 2).
The child had some residual laminin 5 as judged by immuno-
Figure 1. Identi®cation of nonsense muta-
tions within exon 17 of LAMC2 in both
families. (A) Pedigree of families 1 and 2. The
proband of family 1 (C1) died at the age of 6 mo,
the patient of family 2 (C2) died at 10 mo. (B)
Heteroduplex bands were observed with polymer-
ase chain reaction (PCR) products spanning exon
17 and ¯anking intronic sequences in all DNA
samples examined, except in child 1 and father 2.
Lane F1, father 1; lane C1, child 1; lane M1,
mother 1; lane F2, father 2; lane C2, child 2; lane
M2, mother 2. (C) Automated direct sequencing
of the PCR products encompassing exon 17
showed in child 1 a homozygous C-to-T transi-
tion at the nucleotide position 2707 resulting in a
change of Gln to a stop codon (Q864X). (D) The
mutation resulted in loss of a restriction site for
Bcl I endonuclease. A 249 bp product represent-
ing the heterozygous allele was observed in all
samples except in the sample of father 2 showing
a faint band resulting from incomplete digestion.
Child 1 shows complete loss of the restriction site
demonstrating homozygosity for the mutation.
Lane MW, molecular weight markers; lane F1,
C1, M1, F2, C2, M2 as shown above; lane N,
undigested control.
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histochemistry at the dermo±epidermal basement membrane
zone. The initial clinical course was milder, yet the child died at
the age of 10 mo. This pedigree underscores the notion that a
statistical risk of 1.6 3 10±5 is still a practical risk. In this family
screening of the LAMC2 gene of the father for mutations before
initating the pregnancy could have revealed the true risk, 1:4, for
H-JEB.
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Multiple Glomus Tumors of the Skin with Male-to-Male
Transmission Over Four Generations
To the Editor:
Glomus tumors of the skin are benign tumors arising from glomus
bodies or neuromyoarterial receptors that are sensitive to variations
in temperature and regulate arterial ¯ow. The bluish nodules occur
sporadically (mainly as painful solitary tumors on the distal parts of
the extremities) or in a familial pattern (multiple and generally
asymptomatic tumors scattered over the body or localized in a
single area). The inheritance in the few families reported so far has
been autosomal dominant, with some instances of male-to-male
transmission (Tran et al, 1994; Happle and Konig, 1999). In
®ve families, linkage to 1p21-p22, which has been termed
``VMGLOM'' (Boon et al, 1999), was established.
We present a family with a male-to-male transmission over four
generations. All males (n = 14) are affected with glomus tumors of
the angiomatous type (glomangiomas) and all females (n = 10)
remain unaffected (Fig 1). The tumors began to develop at puberty
and involve all parts of the skin except the face, neck, genitals,
palms, and soles. In the 69-y-old index case new lesions are still
developing; in fact, a total of more than 200 have been registered
(Fig 2). The tumors were asymptomatic up to the age of 40 y,
thereafter they started to cause paroxysmal attacks of pain,
aggravated by pressure, trauma, and changes in temperature
(Mullikan and Virnelli-Grevelink, 1999). Histologic examination
of three representative lesions revealed widely dilated vascular
spaces surrounded by ¯at endothelial cells, a ¯at collagen layer, and
clusters of glomus cells containing myo®brils, as seen on electron
Figure 2. Identi®cation of the paternal dele-
tion within intron 3 of LAMC2 in family 2.
(A) Pedigree of families 1 and 2. Heteroduplex of
the PCR products of exon 3 and ¯anking intronic
sequences revealed heteroduplex bands due to the
mutation (see below) in the patient's and his
fathers's DNA (arrow), whereas all other shifts
were polymorphisms. Lane F1, father 1; lane C1,
child 1; lane M1, mother 1; lane F2, father 2; lane
C2, child 2; lane M2, mother 2. (C) Automated
direct sequencing of the PCR product of the
patient's sample showed a 4 bp deletion at posi-
tion +3 adjacent to exon/intron 3 border. (D)
The 521 + 3del4 mutation was con®rmed by re-
striction enzyme digestion. The deletion created a
new restriction site for Mwo I that resulted in di-
gestion of the 315 bp PCR product to 202 bp and
109 bp fragments. Four base points resulting from
an overhang after digestion were not calculated.
The corresponding PCR products representing
maternal DNA and DNA of family 1 remained
undigested. Lane MW, molecular weight markers;
lane F1, C1, M1, F2, C2, M2 as shown above;
lane N, undigested control.
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Figure 1. Pedigree with striking male-to-male transmission. Sym-
bols: s, females, all unaffected; h, males, unaffected, all of them being boys
below the age of 14 y; j, males, affected, ?, died in early childhood, no
other information available.
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